NYSE:MED - Medifast Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $353.33
  • Forecasted Upside: 75.70 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$201.10
▲ +1.83 (0.92%)

This chart shows the closing price for MED by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medifast Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MED

Analyst Price Target is $353.33
▲ +75.70% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Medifast in the last 3 months. The average price target is $353.33, with a high forecast of $400.00 and a low forecast of $265.00. The average price target represents a 75.70% upside from the last price of $201.10.

This chart shows the closing price for MED for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Medifast. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/29/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/23/2021DA DavidsonReiterated RatingBuyC$395.00Medium
5/5/2021B. RileyBoost Price TargetBuy$310.00 ➝ $400.00Medium
5/5/2021DA DavidsonBoost Price TargetBuy$302.00 ➝ $395.00High
3/4/2021DA DavidsonBoost Price TargetBuy$239.00 ➝ $302.00N/A
2/26/2021DA DavidsonBoost Price TargetBuy$239.00 ➝ $302.00Low
2/26/2021B. RileyBoost Price TargetBuy$300.00 ➝ $310.00High
2/19/2021B. RileyBoost Price TargetBuy$250.00 ➝ $300.00Low
1/25/2021Jefferies Financial GroupUpgradeHold ➝ Buy$205.00 ➝ $265.00High
1/12/2021DA DavidsonBoost Price TargetPositive ➝ Buy$205.00 ➝ $239.00Medium
11/5/2020DA DavidsonUpgradeNeutral ➝ Buy$180.00 ➝ $205.00High
11/3/2020B. RileyBoost Price TargetBuy$230.00 ➝ $250.00High
10/9/2020B. RileyBoost Price Target$220.00 ➝ $230.00Medium
10/1/2020Jefferies Financial GroupUpgradeBuy$210.00Medium
8/10/2020DA DavidsonBoost Price TargetNeutral$86.00 ➝ $180.00Low
8/6/2020B. RileyBoost Price Target$164.00 ➝ $220.00Medium
6/25/2020B. RileyInitiated CoverageBuy$164.00High
5/6/2020DA DavidsonBoost Price TargetNeutral$83.00 ➝ $86.00High
2/27/2020DA DavidsonBoost Price TargetNeutral$74.00 ➝ $83.00High
2/27/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$130.00 ➝ $90.00High
1/14/2020Jefferies Financial GroupBoost Price TargetBuy$110.00 ➝ $130.00High
11/8/2019Dougherty & CoDowngradeBuy ➝ NeutralHigh
11/8/2019DA DavidsonDowngradeBuy ➝ Neutral$250.00 ➝ $74.00High
9/23/2019DA DavidsonSet Price TargetBuy$250.00Medium
9/13/2019DA DavidsonSet Price TargetBuy$250.00Low
7/25/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$130.00Medium
2/27/2019SidotiBoost Price TargetBuy ➝ Buy$211.00 ➝ $216.00High
11/8/2018SidotiUpgradeNeutral ➝ BuyMedium
8/3/2018DA DavidsonBoost Price TargetBuy$249.00Low
7/23/2018DA DavidsonBoost Price TargetBuy$201.00Medium
5/24/2018DA DavidsonBoost Price TargetBuy ➝ Buy$135.00 ➝ $161.00High
5/4/2018DA DavidsonBoost Price TargetBuy$135.00High
4/19/2018SidotiReiterated RatingBuy ➝ NeutralMedium
3/8/2018DA DavidsonBoost Price TargetBuy$108.00High
3/7/2018SidotiUpgradeNeutral ➝ BuyHigh
12/8/2017DA DavidsonBoost Price TargetBuy$89.00Medium
9/21/2017SidotiReiterated RatingNeutral$49.00 ➝ $55.00Low
9/15/2017DA DavidsonBoost Price TargetBuy ➝ Buy$65.00 ➝ $74.00High
8/16/2017DA DavidsonInitiated CoverageBuyHigh
5/2/2017SidotiDowngradeBuy ➝ NeutralLow
(Data available from 10/22/2016 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2021
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2021
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2021
  • 6 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2021
  • 5 very positive mentions
  • 26 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/23/2021
  • 10 very positive mentions
  • 23 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
9/22/2021
  • 8 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
10/22/2021

Current Sentiment

  • 8 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Medifast logo
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand-a highly competitive and effective lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.
Read More

Today's Range

Now: $201.10
Low: $198.00
High: $202.69

50 Day Range

MA: $215.83
Low: $185.81
High: $240.14

52 Week Range

Now: $201.10
Low: $139.59
High: $336.99

Volume

997 shs

Average Volume

121,020 shs

Market Capitalization

$2.36 billion

P/E Ratio

15.85

Dividend Yield

2.86%

Beta

1.39

Frequently Asked Questions

What sell-side analysts currently cover shares of Medifast?

The following Wall Street research analysts have issued research reports on Medifast in the last twelve months: B. Riley, DA Davidson, Jefferies Financial Group Inc., and Zacks Investment Research.
View the latest analyst ratings for MED.

What is the current price target for Medifast?

3 Wall Street analysts have set twelve-month price targets for Medifast in the last year. Their average twelve-month price target is $353.33, suggesting a possible upside of 76.1%. B. Riley has the highest price target set, predicting MED will reach $400.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $265.00 for Medifast in the next year.
View the latest price targets for MED.

What is the current consensus analyst rating for Medifast?

Medifast currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MED will outperform the market and that investors should add to their positions of Medifast.
View the latest ratings for MED.

What other companies compete with Medifast?

How do I contact Medifast's investor relations team?

Medifast's physical mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer's listed phone number is (410) 581-8042 and its investor relations email address is [email protected] The official website for Medifast is www.medifast1.com.